IS
ISOLF.US Isodiol International Inc
- Market cap
- USD 4.91K
- P/E
- -
- P/B
- 4.70x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Dec 2019.
Is ISOLF.US undervalued?
Graham numberThe Graham number of Isodiol International Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Isodiol International Inc fundamental analysis
No fundamental analysis for Isodiol International Inc yet.
Isodiol International Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Isodiol International Inc
Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for c…
Full company profileIsodiol International Inc financial statements
2019 annualized: Fiscal year 2019 is not finished. Income statement and cash flow are annualized from 3 quarters up to Dec 31, 2019, the balance sheet is the latest quarter. Figures change when the annual report is published.
Isodiol International Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2019 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0.00 | 13.0K | 267K | 14.8M | 16.7M | 7.55K |
| Gross Profit | 0.00 | 8.02K | 95.0K | -1.90M | -4.05M | 2.01K |
| Operating Income | -721K | -1.91M | -2.59M | -18.1M | -29.2M | -6.87K |
| EBITDA | - | -6.65M | -3.14M | -26.9M | -84.5M | 509K |
| Net Income | -721K | -6.71M | -3.21M | -27.9M | -90.3M | -7.13K |
| EPS | - | -4.53 | -1.01 | -1.33 | -2.35 | -0.15 |
| Balance Sheet | ||||||
| Total Assets | 61.9K | 375K | 1.71M | 42.2M | 17.7M | 8.49K |
| Total Liabilities | 329K | 949K | 281K | 5.20M | 12.5M | 8.81K |
| Shareholders' Equity | -267K | -574K | 1.43M | 37.1M | 5.19M | -319.07 |
| Cash & Short-term Investments | 11.5K | 81.8K | 539K | 12.1M | 2.15M | 1.16K |
| Total Debt | - | 723K | 187K | - | 6.06M | 4.37K |
| Cash Flow | ||||||
| Operating Cash Flow | -500K | -1.18M | -2.13M | -18.2M | -18.0M | 2.70K |
| Capital Expenditure | 44.5K | 44.5K | 44.5K | 5.47M | 3.35M | 0.00 |
| Free Cash Flow | - | -1.18M | -2.17M | -23.7M | -21.3M | 2.70K |
| Ratios | ||||||
| ROE | - | - | -225.1% | -75.4% | -1,739.7% | - |
| ROA | -1,164.4% | -1,790.7% | -188.0% | -66.1% | -510.7% | -84.0% |
| Net Profit Margin | - | -51,697.6% | -1,204.1% | -188.2% | -542.1% | -94.5% |
| Debt to Equity | - | - | 0.13x | - | 1.17x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Isodiol International Inc dividends
Isodiol International Inc has not paid dividends in the last 5 fiscal years.
Last stock split: 1:10 on Jul 24, 2018.
Who owns Isodiol International Inc
Ownership data of Isodiol International Inc is not available yet.
Isodiol International Inc company profile
- Company name
- Isodiol International Inc
- Ticker
- ISOLF.US
- ISIN
- CA46500L2003
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- March
- Address
- 200 Granville Street, Vancouver, BC, Canada, V6C 1S4
- Phone
- 604 409 4409
- Website
- isodiol.com
About Isodiol International Inc
Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.
Isodiol International Inc management
6- Mr. Marcos AgramontCEO & Director
- Mr. Patrick Edward Ogle J.D., L.L.M.COO & Director
- Mr. Marvin WashingtonVP & Director of Business Development and Director
- Mr. Soheil SamimiAdvisor
- Mr. Andrew Stanton AlvisPresident, Interim CFO & Director
- Mr. Kevin W. SwadishChief Revenue Officer